Table 2.
Patients | |
---|---|
Sex (male/female) | 29/11 |
Mean age years (range) | 67 (45–81) |
Higher CD38 expression (score 3–5/tested cases) |
7/39 |
Higher ZAP70 expression (score 3–5/tested cases) |
21/34 |
Mean Ki-67 percentage (range) | 24% (2.5%–90%) |
Overall survival months median (range) | 42 (5–120) |